American CryoStem (OTCQB: CRYO) Announces Partnership with Orlando Florida Medical Rejuvenation Center (Eterna M.D.) to offer ATGRAFT™ Fat Storage Service for Natural Cosmetic Enhancements to their Patients
Company continues to develop new revenue streams by targeting multiple billion dollar Cosmetic industry
EATONTOWN, N.J., -January 30, 2013 – American CryoStem Corporation (OTCQB:CRYO), a leading biotech company in the field of Regenerative Medicine, is proud to announce that Eterna M.D. of Orlando, FL will be offering American CryoStem’s new ATGRAFT™ fat storage service to their patients for future natural cosmetic enhancements.
By using the ATGRAFT™ fat storage service, Eterna M.D. patient’s can access selected sizes of their stored fat to undergo layered fat transfer procedures over time.
With this new service, a patient can undergo a standard liposuction and store their excess body fat as a natural biocompatible filler for a fuller, more natural look and feel for immediate or future use in cosmetic enhancement procedures. Demand for liposuction surgery has been on the rise and thanks to new technologies patients can make good use of their unwanted body fat resulting from a liposuction and save it for future procedures.
Fat transfers offer the most natural look and feel for aesthetic augmentation and corrective cosmetic procedures. An alternative to synthetic materials, patients can use fat from an undesired location to enhance a multitude of areas throughout their body. Storing a patient’s fat tissue for cosmetic enhancements provides them with many benefits not available from a one-time fat transfer procedure. Patient’s can now have one liposuction and simply visit Eterna M.D. for multiple transfer procedures by using their stored tissue for more a pleasing, natural result.
“The wave of the future for cosmetic and regenerative medicine relies on fat transfer and storage. Having the ability to store the fat and retrieve it to be used either as “intelligent fillers” or for future Regenerative Medicine procedures since they are rich in growth factors and stem cells”. Stated Dr. Mercado, owner of Eterna M.D. “I firmly believe this the way of the future, to store your fat following liposuction procedures for future cosmetic procedures or to retrieve your stem cells from your own stored fat for clinical applications such as osteoarthritis and sports injury is a breakthrough in medicine.”
American CryoStem’s ATGRAFT™ tissue storage customers also have additional opportunities to further process portions of their clinically prepared adipose tissue samples for future uses in Regenerative Medicine therapies or to create personalized skin care products made from their own adult stem cells.
Physicians that would like to offer ATGRAFT™ tissue storage services to their patients should call 732-747-1007 or email email@example.com for an informational kit.
About American CryoStem: American CryoStem Corporation (OTCQB: CRYO) is a leading biotech company focused on marketing its clinical processing services and patented products for adipose (fat) tissue and adipose derived adult stem cells. Our clinical tissue processing, patented cell culture media products and tissue storage platform supports cosmetic and regenerative medicine applications being developed globally. The Company provides high quality, clinically processed viable cells, while at the same time developing cutting edge applications, therapies, patented laboratory products and services for consumer and commercial applications.
Cautionary Statements Concerning Forward-Looking Statements
This Press Release contains “forward-looking” statements as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on management’s current expectations or predictions of future conditions, events or results based on various assumptions and management’s estimates of trends and economic factors in the markets in which we are active, as well as our business plans. Words such as “expects”, “anticipates”, “intends”, “plans”, “believes”, “seeks”, “estimates”, “projects”, “forecasts”, “may”, “should”, variations of such words and similar expressions are intended to identify such forward-looking statements. The forward-looking statements may include, without limitation, statements regarding product development, product potential or financial performance. The forward-looking statements are subject to risks and uncertainties, which may cause results to differ materially from those set forth in the statements. Forward-looking statements in this release should be evaluated together with the many uncertainties that affect the business of American CryoStem Corp. and its markets, particularly those discussed in the risk factors and cautionary statements in filings made by the Company with the Securities and Exchange Commission. Forward-looking statements are not guarantees of future performance, and actual results may differ materially from those projected. The forward-looking statements are representative only as of the date they are made, and the Company assumes any responsibility to update any forward-looking statements, whether as a result of new information, future events or otherwise.
Investor Relations Contact:
American CryoStem Corporation